A Conversation With Stephen W. Schondelmeyer. Drug and Health Care Spending: A Bubble That Will Burst Unless We Do Something.
This professor of pharmaceutical economics in the University of Minnesota College of Pharmacy says that the rising level of health care spending is unsustainable. He argues that drug price increases should be reviewed and PBMs should be regulated. "We need [a] bona fide rate regulation review body that can meaningfully evaluate the information presented by drug companies."